Dominic Williams

Associate Director

Preclinical Hepatic Safety

(AstraZeneca)

Dominic completed his PhD in Pharmacology at the University of Liverpool in 1999. He spent 6 years as a researcher at the MRC Centre for drug safety science. His interests lie in pharmacology and toxicology and he is an expert in hepatic translational safety at AstraZeneca. He has have worked on the role of conjugative metabolism in hepatotoxicity of carboxylic-acid-containing drugs. He currently works on role of liver sinusoidal endothelial cells (LSECs) in hepatotoxicity using cutting-edge techniques in molecular research.

REGISTER NOW AND SAVE UP TO £210